Biotech Primer Introduces NASBA-Compliant CPE Courses for Finance and Accounting Professionals
Press Release | Oct 29, 2024
*Baltimore, MD* – Biotech Primer, renowned for its expertise in biotechnology and life sciences education, is pleased to announce the launch of its new NASBA-compliant Continuing Professional Education (CPE) Credits. These courses offer finance and accounting professionals a unique opportunity to deepen their understanding of the rapidly evolving biopharmaceutical and medical device sectors.
As the life science industry continues to grow and innovate at an unprecedented pace, the need for finance professionals to stay informed is greater than ever. Biotech Primer’s CPE courses teach participants the intricacies of the healthcare landscape, from product development processes to regulatory environments, through a financial lens. The curriculum has been carefully designed to address the unique needs of professionals working with biotech companies or clients in related industries.
Key Features of Biotech Primer’s New CPE Course Offerings:
~ NASBA Approved: Biotech Primer is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. This ensures that finance professionals can trust the quality and compliance of the credits earned through these courses.
~ Specialized Knowledge: The courses dive deep into business models, product development, manufacturing processes, commercialization, and more, all tailored to enhance the financial decision-making of professionals working in the life sciences space.
~ Flexible, Online Learning: Delivered in an on-demand format, the courses offer participants the convenience of learning at their own pace, on their own schedule, from anywhere, while fulfilling their CPE credit requirements.
~ Expert-Led Instruction: Each course is developed by industry veterans with deep expertise in the business of biopharmaceuticals and medical devices, ensuring that participants gain practical, real-world knowledge and actionable insights they can immediately apply to their roles.
“Biotech Primer has always been dedicated to bridging the gap between science and business. With these new CPE courses, we’re embracing that commitment by providing finance professionals with the knowledge they need to navigate the complexities of the life science industry confidently,” said Stacey Hawkins, CEO of Biotech Primer. “Our NASBA-compliant courses offer a unique opportunity for accountants and financial experts to deepen their understanding and excel in their roles.”
Biotech Primer’s new CPE courses are now available. To learn more and enroll, visit [Biotech Primer’s CPE Course Page] https://biotechprimer.com/shop-cpe-courses-nasba-compliant
About Biotech Primer
Biotech Primer is a trusted leader in delivering life science training that simplifies complex topics for non-scientists. With over 20 years of experience, industry-specific courses are expertly crafted to provide a clear understanding of the science, business, and regulatory frameworks essential for success in Biotechnology, Pharmaceuticals, Molecular Diagnostics, and Medical Devices. Known for a practical, real-world approach, Biotech Primer ensures participants gain valuable, applicable skills that drive innovation and growth within their organizations.
For media inquiries, please contact:
Stacey Hawkins
Biotech Primer
—
Biotech Primer is registered with the National Association of State Boards of Accountancy (NASBA) as a sponsor of continuing professional education on the National Registry of CPE Sponsors. State boards of accountancy have final authority on the acceptance of individual courses for CPE credit. Complaints regarding registered sponsors may be submitted to the National Registry of CPE Sponsors through its website: NASBAregistry.org.